His main research concerns Internal medicine, Immunology, Cohort study, Cohort and Viral load. His Internal medicine research includes elements of Gastroenterology and Hepatitis C virus. His work carried out in the field of Immunology brings together such families of science as Single-nucleotide polymorphism and Haplotype.
His Cohort study research is multidisciplinary, relying on both Prospective cohort study, Incidence, Confidence interval and Comorbidity. His Cohort research is multidisciplinary, incorporating elements of Absolute risk reduction, Risk of mortality, Young adult, Gerontology and Acquired immunodeficiency syndrome. His work is dedicated to discovering how Odds ratio, Virology are connected with Genotype and Genetics and other disciplines.
His primary areas of study are Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort and Cohort study. His work investigates the relationship between Internal medicine and topics such as Gastroenterology that intersect with problems in Fibrosis. The study incorporates disciplines such as Single-nucleotide polymorphism, Incidence and Virology in addition to Immunology.
His Acquired immunodeficiency syndrome study also includes
His scientific interests lie mostly in Internal medicine, Cohort, Acquired immunodeficiency syndrome, Cohort study and Hepatitis C virus. Gregory D. Kirk usually deals with Internal medicine and limits it to topics linked to Gastroenterology and Hepatocellular carcinoma and Coinfection. His biological study spans a wide range of topics, including Hepatitis B, Hepatitis C, Harm reduction, Biomarker and Prospective cohort study.
Gregory D. Kirk has included themes like Mental health, Methylation, Proportional hazards model and Viral load in his Acquired immunodeficiency syndrome study. While the research belongs to areas of Cohort study, Gregory D. Kirk spends his time largely on the problem of Substance abuse, intersecting his research to questions surrounding Cross-sectional study and Emergency medicine. Hepatitis C virus is the topic of his studies on Immunology and Virology.
The scientist’s investigation covers issues in Internal medicine, Acquired immunodeficiency syndrome, Cohort, Odds ratio and Confidence interval. His study on Liver disease and Cohort study is often connected to Weight gain as part of broader study in Internal medicine. In general Acquired immunodeficiency syndrome, his work in Dolutegravir, Raltegravir and Integrase inhibitor is often linked to Weight change linking many areas of study.
His studies deal with areas such as Harm reduction, Elvitegravir, Disease and Viral load as well as Cohort. His Odds ratio research incorporates themes from SNP, Genome-wide association study, Genotype, 1000 Genomes Project and Single-nucleotide polymorphism. His Hazard ratio study in the realm of Confidence interval interacts with subjects such as Association.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
Alison G. Abraham;Gypsyamber D'Souza;Yuezhou Jing;Stephen J. Gange.
Journal of Acquired Immune Deficiency Syndromes (2013)
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Gregory D Kirk;Olufunmilayo A Lesi;Maimuna Mendy;Katarzyna Szymañska.
Oncogene (2005)
Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
Stephen J Gange;Mari M Kitahata;Michael S Saag;David R Bangsberg.
International Journal of Epidemiology (2007)
Mortality among cocaine users: a systematic review of cohort studies.
Louisa Degenhardt;Jessica Singleton;Bianca Calabria;Jennifer McLaren.
Drug and Alcohol Dependence (2011)
Assessment of Liver Fibrosis by Transient Elastography in Persons with Hepatitis C Virus Infection or HIV–Hepatitis C Virus Coinfection
Gregory D. Kirk;Jacquie Astemborski;Shruti H. Mehta;Chuck Spoler.
Clinical Infectious Diseases (2009)
HIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease: A Cohort Study
Gregory D. Kirk;Shruti H. Mehta;Jacquie Astemborski;Noya Galai.
Annals of Internal Medicine (2013)
Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa.
Gregory D. Kirk;Ebrima Bah;Ruggero Montesano.
Carcinogenesis (2006)
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis
Amy C. Justice;Sharada P. Modur;Janet P. Tate;Keri N. Althoff.
Journal of Acquired Immune Deficiency Syndromes (2013)
Changes in Blood-borne Infection Risk Among Injection Drug Users
Shruti H. Mehta;Jacqueline Astemborski;Gregory D. Kirk;Steffanie A. Strathdee.
The Journal of Infectious Diseases (2011)
Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection
Hassan Javanbakht;Ping An;Bert Gold;Desiree C. Petersen.
Virology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
National Institutes of Health
Johns Hopkins University
University College London
Johns Hopkins University
National Institutes of Health
National Institutes of Health
University of California, San Francisco
Vanderbilt University
Johns Hopkins University
Yonsei University
University of California, San Diego
Commonwealth Scientific and Industrial Research Organisation
Versailles Saint-Quentin-en-Yvelines University
Purdue University West Lafayette
Yale University
Rutgers, The State University of New Jersey
Zhejiang University
Warsaw University of Life Sciences
University of Alabama in Huntsville
University of Pennsylvania
Geneva College
Mayo Clinic
University of Leeds
University of Sheffield
Harvard University